The Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI) is the bi-ennial conference for the Asia Pacific Society of Clinical Microbiology and Infection (APSCMI). The first congress was held in Kuala Lumpur in 1989. It was re-named from the Western Pacific Congress on Chemotherapy and Infectious Diseases (WPCCID) since 2012, when the Society was also re-named from Western Pacific Society of Chemotherapy (WPSC).

The Society of Infectious Diseases (Singapore) organised WPCCID in 1996 and 2010. SIDS is delighted to be the local organiser for APCCMI 2021 (www.apccmi2021.com) once again on 11 to 13 November 2021 at Suntec City Convention Centre, Singapore.

APCCMI 2021 will build on this rich history in Singapore and regional collaboration. The congress will focus on:

1. COVID-19
2. Advances in infection control, microbiome and vaccines; new antimicrobials and antimicrobial stewardship.
3. Advances in microbiology including rapid diagnostics, applications in whole genome sequencing, laboratory automation;
4. Antimicrobial resistance in humans and within the One Health context of animals, humans and the environment;
5. Challenges and progress in the three pandemic infections of HIV, Malaria and Tuberculosis;
6. Emerging infectious diseases prevalent in the region (Chikungunya, Dengue, Zika) and globally (Avian and seasonal influenza, MERS-CoV);

• There will be at least two plenary lectures and six concurrent symposia per day, with early morning meet-the-expert and lunch time sponsored symposia.
• Poster and oral presentations will be invited with travel awards for best abstract.
• Limited places will be available to visit the National Centre for Infectious Diseases.

More updates will be announced on our website, and please look out for email updates via our regional partner societies and associations.

We look forward to welcoming you to Singapore in 2021.